skip to Main Content

Cancer Services

Urogential and Prostate Cancer

Please see below all current urogenital and prostate cancer clinical trials of the Central Coast Cancer Centre.

Name: N/A

A Phase 2, Open-Label, Single-Arm Study of Pamiparib (BGB-290) for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Homologous Recombination Deficiency (HRD).

Principal Investigator: Dr Matthew Chan
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Prostate cancer
External page link More information about this trial

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:

Internal page Research and Clinical Trials

Back To Top